Page 2 - Cogent Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spea...

Share: TM device and disposable test cassette       -          Q-POC™ is a point of care molecular diagnostic system which delivers results in approximately 30 minutes; first application in COVID-19                NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over £11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC™ and disposable test cassette. QuantuMDx accelerated d...